Results 311 to 320 of about 106,395 (322)
Some of the next articles are maybe not open access.
European Journal of Pharmacology, 1998
The anti-inflammatory activity of drugs more selective for cyclooxgenase isoform inhibition (cyclooxygenase 1, cyclooxygenase 2), were compared in rat carrageenin-induced pleurisy. Suppression of inflammation by cyclooxygenase 2-selective inhibitors, NS-398 (N-[-2-cyclohexyloxy]-4-nitrophenyl methanesulphonamide) and nimesulide (4-nitro-2-phenoxy ...
Annette Tomlinson+2 more
openaire +3 more sources
The anti-inflammatory activity of drugs more selective for cyclooxgenase isoform inhibition (cyclooxygenase 1, cyclooxygenase 2), were compared in rat carrageenin-induced pleurisy. Suppression of inflammation by cyclooxygenase 2-selective inhibitors, NS-398 (N-[-2-cyclohexyloxy]-4-nitrophenyl methanesulphonamide) and nimesulide (4-nitro-2-phenoxy ...
Annette Tomlinson+2 more
openaire +3 more sources
Selective Cyclooxygenase-2 Inhibitors
2004Publisher Summary Cyclooxygenase (prostaglandin G/H synthase) catalyzes the conversion of arachidonic acid (AA) into prostaglandin H2 as the first committed step of prostaglandin biosynthesis. This enzyme is known to be the target of acetyl salicylic acid (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs).
openaire +2 more sources
The economic implications of cyclooxygenase-2–specific inhibitors
The American Journal of Medicine, 2001Rheumatoid arthritis and osteoarthritis are prevalent and costly conditions. A large proportion of the direct costs associated with these conditions relates to management of iatrogenic side effects. The cyclooxygenase (COX)-2-specific inhibitors lead to equivalent control of pain and disability compared with traditional NSAIDs.
James M. Scheiman, Paul M. Peloso
openaire +3 more sources
Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Current Pharmaceutical Design, 2003Cyclooxygenase-1 (COX-1) derived eicosanoids promote gastroprotective mucosal defenses and induce platelet aggregation. By sparing COX-1, COX-2 specific inhibitors provide effective anti-inflammatory and analgesic activity while substantially reducing the risk of peptic ulcer disease and GI bleeding compared to dual COX inhibitors (traditional NSAIDs).
openaire +3 more sources
Cardiovascular effects of selective cyclooxygenase-2 inhibitors
Expert Review of Cardiovascular Therapy, 2004Selective cyclooxygenase-2 inhibitors represent a significant advance in the management of inflammatory disorders. They have similar efficacy to nonselective 'conventional' nonsteroidal anti-inflammatory drugs, but a superior gastrointestinal safety profile.
Henry Krum+3 more
openaire +3 more sources
5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)
1999Publisher Summary This chapter focuses on selective inhibitors of cyclooxygenase-2 (COX-2). Two distinct COX enzymes were recently identified (i) a constitutive form (COX-1) present in tissues such as gut and kidney that produces prostaglandins (PGs) that are necessary for normal physiological function, (ii) an inducible form (COX-2) whose expression
openaire +3 more sources
Correction: Cyclooxygenase-2 Inhibitors
Annals of Pharmacotherapy, 1999Barbara Storyk Klostermeyer+1 more
openaire +2 more sources
Aspirin and cyclooxygenase-2 inhibitors
American Journal of Health-System Pharmacy, 2003openaire +2 more sources
The effect of cyclooxygenase-2 inhibitors on bone healing
Regional Anesthesia and Pain Medicine, 2003openaire +3 more sources